BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

475 related articles for article (PubMed ID: 26204305)

  • 1. Real-Time MRI-Guided Focused Ultrasound for Focal Therapy of Locally Confined Low-Risk Prostate Cancer: Feasibility and Preliminary Outcomes.
    Ghai S; Louis AS; Van Vliet M; Lindner U; Haider MA; Hlasny E; Spensieri P; Van Der Kwast TH; McCluskey SA; Kucharczyk W; Trachtenberg J
    AJR Am J Roentgenol; 2015 Aug; 205(2):W177-84. PubMed ID: 26204305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnetic resonance guided focused high frequency ultrasound ablation for focal therapy in prostate cancer - phase 1 trial.
    Ghai S; Perlis N; Lindner U; Hlasny E; Haider MA; Finelli A; Zlotta AR; Kulkarni GS; van der Kwast TH; McCluskey SA; Kucharczyk W; Trachtenberg J
    Eur Radiol; 2018 Oct; 28(10):4281-4287. PubMed ID: 29696431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Location of Prostate Cancers Determined by Multiparametric and MRI-Guided Biopsy in Patients With Elevated Prostate-Specific Antigen Level and at Least One Negative Transrectal Ultrasound-Guided Biopsy.
    Schouten MG; Hoeks CM; Bomers JG; Hulsbergen-van de Kaa CA; Witjes JA; Thompson LC; Rovers MM; Barentsz JO; Fütterer JJ
    AJR Am J Roentgenol; 2015 Jul; 205(1):57-63. PubMed ID: 26102380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Focal Therapy for Prostate Cancer with In-Bore MR-guided Focused Ultrasound: Two-Year Follow-up of a Phase I Trial-Complications and Functional Outcomes.
    Tay KJ; Cheng CWS; Lau WKO; Khoo J; Thng CH; Kwek JW
    Radiology; 2017 Nov; 285(2):620-628. PubMed ID: 28654336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective evaluation of magnetic resonance imaging guided in-bore prostate biopsy versus systematic transrectal ultrasound guided prostate biopsy in biopsy naïve men with elevated prostate specific antigen.
    Quentin M; Blondin D; Arsov C; Schimmöller L; Hiester A; Godehardt E; Albers P; Antoch G; Rabenalt R
    J Urol; 2014 Nov; 192(5):1374-9. PubMed ID: 24866597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II Evaluation of Magnetic Resonance Imaging Guided Focal Laser Ablation of Prostate Cancer.
    Eggener SE; Yousuf A; Watson S; Wang S; Oto A
    J Urol; 2016 Dec; 196(6):1670-1675. PubMed ID: 27449263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective Multicenter Phase II Study on Focal Therapy (Hemiablation) of the Prostate with High Intensity Focused Ultrasound.
    Ganzer R; Hadaschik B; Pahernik S; Koch D; Baumunk D; Kuru T; Heidenreich A; Stolzenburg JU; Schostak M; Blana A
    J Urol; 2018 Apr; 199(4):983-989. PubMed ID: 29107031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate cancer treatment by the latest focal HIFU device with MRI/TRUS-fusion control biopsies: A prospective evaluation.
    von Hardenberg J; Westhoff N; Baumunk D; Hausmann D; Martini T; Marx A; Porubsky S; Schostak M; Michel MS; Ritter M
    Urol Oncol; 2018 Sep; 36(9):401.e1-401.e9. PubMed ID: 30093211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Focal High-intensity Focused Ultrasound Targeted Hemiablation for Unilateral Prostate Cancer: A Prospective Evaluation of Oncologic and Functional Outcomes.
    Feijoo ER; Sivaraman A; Barret E; Sanchez-Salas R; Galiano M; Rozet F; Prapotnich D; Cathala N; Mombet A; Cathelineau X
    Eur Urol; 2016 Feb; 69(2):214-20. PubMed ID: 26164416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetic Resonance Imaging-Guided Transurethral Ultrasound Ablation of Prostate Tissue in Patients with Localized Prostate Cancer: A Prospective Phase 1 Clinical Trial.
    Chin JL; Billia M; Relle J; Roethke MC; Popeneciu IV; Kuru TH; Hatiboglu G; Mueller-Wolf MB; Motsch J; Romagnoli C; Kassam Z; Harle CC; Hafron J; Nandalur KR; Chronik BA; Burtnyk M; Schlemmer HP; Pahernik S
    Eur Urol; 2016 Sep; 70(3):447-55. PubMed ID: 26777228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MRI-guided Focused Ultrasound Ablation for Localized Intermediate-Risk Prostate Cancer: Early Results of a Phase II Trial.
    Ghai S; Finelli A; Corr K; Chan R; Jokhu S; Li X; McCluskey S; Konukhova A; Hlasny E; van der Kwast TH; Incze PF; Zlotta AR; Hamilton RJ; Haider MA; Kucharczyk W; Perlis N
    Radiology; 2021 Mar; 298(3):695-703. PubMed ID: 33529137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution and outcomes of 3 MHz high intensity focused ultrasound therapy for localized prostate cancer during 15 years.
    Thüroff S; Chaussy C
    J Urol; 2013 Aug; 190(2):702-10. PubMed ID: 23415962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endorectal magnetic resonance imaging and magnetic resonance spectroscopy to monitor the prostate for residual disease or local cancer recurrence after transrectal high-intensity focused ultrasound.
    Cirillo S; Petracchini M; D'Urso L; Dellamonica P; Illing R; Regge D; Muto G
    BJU Int; 2008 Aug; 102(4):452-8. PubMed ID: 18476973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Localising prostate cancer: comparison of endorectal magnetic resonance (MR) imaging and 3D-MR spectroscopic imaging with transrectal ultrasound-guided biopsy.
    Goris Gbenou MC; Peltier A; Addla SK; Lemort M; Bollens R; Larsimont D; Roumeguère T; Schulman CC; van Velthoven R
    Urol Int; 2012; 88(1):12-7. PubMed ID: 22004874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Focal Laser Ablation of Prostate Cancer: Feasibility of Magnetic Resonance Imaging-Ultrasound Fusion for Guidance.
    Natarajan S; Jones TA; Priester AM; Geoghegan R; Lieu P; Delfin M; Felker E; Margolis DJA; Sisk A; Pantuck A; Grundfest W; Marks LS
    J Urol; 2017 Oct; 198(4):839-847. PubMed ID: 28396184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Focal cryotherapy for clinically unilateral, low-intermediate risk prostate cancer in 73 men with a median follow-up of 3.7 years.
    Bahn D; de Castro Abreu AL; Gill IS; Hung AJ; Silverman P; Gross ME; Lieskovsky G; Ukimura O
    Eur Urol; 2012 Jul; 62(1):55-63. PubMed ID: 22445223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Focal High Intensity Focused Ultrasound of Unilateral Localized Prostate Cancer: A Prospective Multicentric Hemiablation Study of 111 Patients.
    Rischmann P; Gelet A; Riche B; Villers A; Pasticier G; Bondil P; Jung JL; Bugel H; Petit J; Toledano H; Mallick S; Rouvière O; Rabilloud M; Tonoli-Catez H; Crouzet S
    Eur Urol; 2017 Feb; 71(2):267-273. PubMed ID: 27720531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MR imaging-guided focal laser ablation for prostate cancer: phase I trial.
    Oto A; Sethi I; Karczmar G; McNichols R; Ivancevic MK; Stadler WM; Watson S; Eggener S
    Radiology; 2013 Jun; 267(3):932-40. PubMed ID: 23440319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted prostate biopsy and MR-guided therapy for prostate cancer.
    Woodrum DA; Kawashima A; Gorny KR; Mynderse LA
    Abdom Radiol (NY); 2016 May; 41(5):877-88. PubMed ID: 26907717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MR-guided prostate biopsy for planning of focal salvage after radiation therapy.
    Ménard C; Iupati D; Publicover J; Lee J; Abed J; O'Leary G; Simeonov A; Foltz WD; Milosevic M; Catton C; Morton G; Bristow R; Bayley A; Atenafu EG; Evans AJ; Jaffray DA; Chung P; Brock KK; Haider MA
    Radiology; 2015 Jan; 274(1):181-91. PubMed ID: 25203127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.